Case Report
BibTex RIS Cite
Year 2024, Volume: 4 Issue: 1, 7 - 10, 14.05.2024

Abstract

References

  • Nakajo M, Jinnouchi S, Noguchi M, Uozumi K, Tanabe H, Tateno R, Nakajo M. FDG PET and PET/CT monitoring of autoimmune pancreatitis associated with extrapancreatic autoimmune disease. Clin Nucl Med. 2007 Apr;32(4):282-5. doi: 10.1097/01.rlu.0000257295.12017.ab.
  • Nakajo M, Jinnouchi S, Fukukura Y, Tanabe H, Tateno R, Nakajo M. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2088-95. doi: 10.1007/s00259-007-0562-7.
  • Nanni C, Romagnoli R, Rambaldi I, Caroli P, Matteucci F, Ambrosini V, Re G, Fanti S. FDG PET/CT in autoimmune pancreatitis. Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1264-5. doi: 10.1007/s00259-014-2699-5.
  • Santhosh S, Bhattacharya A, Harisankar CN, Kochhar R, Mittal BR. Role of 18F-FDG PET/CT in the management of a case of autoimmune pancreatitis with extrapancreatic manifestations. Clin Nucl Med. 2013 Nov;38(11):e423-5. doi: 10.1097/RLU.0b013e31827086b5.
  • Nakajo M, Jinnouchi S, Fukukura Y, Tanabe H, Tateno R, Nakajo M. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2088-95. doi: 10.1007/s00259-007-0562-7.
  • Dong A, Cui Y, Gao L, Wang Y, Zuo C, Yang J. Patterns of FDG uptake in pancreatic non-Hodgkin's lymphoma lesions. Abdom Imaging. 2014 Feb;39(1):175-86. doi: 10.1007/s00261-013-0041-5.
  • Schaefer, N. G., Hany, T. F., Taverna, C., Seifert, B., Stumpe, K. D., von Schulthess, G. K., & Goerres, G. W. (2004). Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?. Radiology, 232(3), 823–829. https://doi.org/10.1148/radiol.2323030985
  • Zhang, J., Shao, C., Wang, J., Cheng, C., Zuo, C., Sun, G., Cui, B., Dong, A., Liu, Q., & Kong, L. (2013). Autoimmune pancreatitis: whole-body 18F-FDG PET/CT findings. Abdominal imaging, 38(3), 543–549. https://doi.org/10.1007/s00261-012-9966-3
  • Sireesha P, Nithya V, Surya G, Hemalatha DS, Kalawat T, Kumar VS, Priya RR. A Rare Finding of Pancreatic Involvement in a Case of Burkitt's Lymphoma. Indian J Nucl Med. 2023 Jan-Mar;38(1):59-62. doi: 10.4103/ijnm.ijnm_108_22.
  • Arslan E, Aksoy T, Alçın G, Ermantaş N, Özlük Y, Yeğen G, Çermik TF. Diffuse Large B-Cell Non-Hodgkin Lymphoma Involving Multiple Different Organs in a Young Adult with 18F-FDG PET/CT. Mol Imaging Radionucl Ther. 2022 Feb 2;31(1):72-74. doi: 10.4274/mirt.galenos.2021.28190.
  • Farahmandfar F, Shakeri S, Moradian S, Shahlaei S, Sadeghi R. Primary skeletal muscle lymphoma with unusual soft tissue metastases in the stomach and pancreas detected by 18F-FDG PET/CT. Nucl Med Rev Cent East Eur. 2020;23(2):108-109. doi: 10.5603/NMR.2020.0021.

Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Year 2024, Volume: 4 Issue: 1, 7 - 10, 14.05.2024

Abstract

This is the report of three cases with diagnosis of Lymphoma who has pancreatic involvement as well as disseminated disease presentation as demonstrated by F-18 FDG PET/CT.

References

  • Nakajo M, Jinnouchi S, Noguchi M, Uozumi K, Tanabe H, Tateno R, Nakajo M. FDG PET and PET/CT monitoring of autoimmune pancreatitis associated with extrapancreatic autoimmune disease. Clin Nucl Med. 2007 Apr;32(4):282-5. doi: 10.1097/01.rlu.0000257295.12017.ab.
  • Nakajo M, Jinnouchi S, Fukukura Y, Tanabe H, Tateno R, Nakajo M. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2088-95. doi: 10.1007/s00259-007-0562-7.
  • Nanni C, Romagnoli R, Rambaldi I, Caroli P, Matteucci F, Ambrosini V, Re G, Fanti S. FDG PET/CT in autoimmune pancreatitis. Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1264-5. doi: 10.1007/s00259-014-2699-5.
  • Santhosh S, Bhattacharya A, Harisankar CN, Kochhar R, Mittal BR. Role of 18F-FDG PET/CT in the management of a case of autoimmune pancreatitis with extrapancreatic manifestations. Clin Nucl Med. 2013 Nov;38(11):e423-5. doi: 10.1097/RLU.0b013e31827086b5.
  • Nakajo M, Jinnouchi S, Fukukura Y, Tanabe H, Tateno R, Nakajo M. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2088-95. doi: 10.1007/s00259-007-0562-7.
  • Dong A, Cui Y, Gao L, Wang Y, Zuo C, Yang J. Patterns of FDG uptake in pancreatic non-Hodgkin's lymphoma lesions. Abdom Imaging. 2014 Feb;39(1):175-86. doi: 10.1007/s00261-013-0041-5.
  • Schaefer, N. G., Hany, T. F., Taverna, C., Seifert, B., Stumpe, K. D., von Schulthess, G. K., & Goerres, G. W. (2004). Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?. Radiology, 232(3), 823–829. https://doi.org/10.1148/radiol.2323030985
  • Zhang, J., Shao, C., Wang, J., Cheng, C., Zuo, C., Sun, G., Cui, B., Dong, A., Liu, Q., & Kong, L. (2013). Autoimmune pancreatitis: whole-body 18F-FDG PET/CT findings. Abdominal imaging, 38(3), 543–549. https://doi.org/10.1007/s00261-012-9966-3
  • Sireesha P, Nithya V, Surya G, Hemalatha DS, Kalawat T, Kumar VS, Priya RR. A Rare Finding of Pancreatic Involvement in a Case of Burkitt's Lymphoma. Indian J Nucl Med. 2023 Jan-Mar;38(1):59-62. doi: 10.4103/ijnm.ijnm_108_22.
  • Arslan E, Aksoy T, Alçın G, Ermantaş N, Özlük Y, Yeğen G, Çermik TF. Diffuse Large B-Cell Non-Hodgkin Lymphoma Involving Multiple Different Organs in a Young Adult with 18F-FDG PET/CT. Mol Imaging Radionucl Ther. 2022 Feb 2;31(1):72-74. doi: 10.4274/mirt.galenos.2021.28190.
  • Farahmandfar F, Shakeri S, Moradian S, Shahlaei S, Sadeghi R. Primary skeletal muscle lymphoma with unusual soft tissue metastases in the stomach and pancreas detected by 18F-FDG PET/CT. Nucl Med Rev Cent East Eur. 2020;23(2):108-109. doi: 10.5603/NMR.2020.0021.
There are 11 citations in total.

Details

Primary Language English
Subjects Gastroenterology and Hepatology, Nuclear Medicine, Haematological Tumours, Oncology and Carcinogenesis (Other)
Journal Section Case Reports
Authors

Zehra Pınar Koç

Pınar Pelin Özcan 0000-0003-0147-2678

Serkan Yaraş

Publication Date May 14, 2024
Submission Date April 4, 2024
Acceptance Date May 14, 2024
Published in Issue Year 2024 Volume: 4 Issue: 1

Cite

APA Koç, Z. P., Özcan, P. P., & Yaraş, S. (2024). Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging, 4(1), 7-10.
AMA Koç ZP, Özcan PP, Yaraş S. Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging. May 2024;4(1):7-10.
Chicago Koç, Zehra Pınar, Pınar Pelin Özcan, and Serkan Yaraş. “Pancreatic Involvement of Lymphoma As Determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography”. Molecular Oncologic Imaging 4, no. 1 (May 2024): 7-10.
EndNote Koç ZP, Özcan PP, Yaraş S (May 1, 2024) Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging 4 1 7–10.
IEEE Z. P. Koç, P. P. Özcan, and S. Yaraş, “Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography”, Molecular Oncologic Imaging, vol. 4, no. 1, pp. 7–10, 2024.
ISNAD Koç, Zehra Pınar et al. “Pancreatic Involvement of Lymphoma As Determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography”. Molecular Oncologic Imaging 4/1 (May 2024), 7-10.
JAMA Koç ZP, Özcan PP, Yaraş S. Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging. 2024;4:7–10.
MLA Koç, Zehra Pınar et al. “Pancreatic Involvement of Lymphoma As Determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography”. Molecular Oncologic Imaging, vol. 4, no. 1, 2024, pp. 7-10.
Vancouver Koç ZP, Özcan PP, Yaraş S. Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging. 2024;4(1):7-10.